These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16985688)
1. Caseating granulomas on the glans penis as a complication of bacille calmette-guérin intravesical therapy. French CG; Hickey L; Bell DG Rev Urol; 2001; 3(1):36-8. PubMed ID: 16985688 [TBL] [Abstract][Full Text] [Related]
3. A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection. Colomba C; Di Carlo P; Guadagnino G; Siracusa L; Trizzino M; Gioè C; Cascio A Infect Agent Cancer; 2016; 11():25. PubMed ID: 27257433 [TBL] [Abstract][Full Text] [Related]
4. [BCG infection of the glans penis after intravesical BCG therapy]. Michelet N; Spenatto N; Viraben R; Cuny JF; Mazet J; Trechot P; Barbaud A; Schmutz JL Ann Dermatol Venereol; 2008; 135(6-7):479-83. PubMed ID: 18598797 [TBL] [Abstract][Full Text] [Related]
6. Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin. Lestre SI; Gameiro CD; João A; Lopes MJ An Bras Dermatol; 2011; 86(4):759-62. PubMed ID: 21987145 [TBL] [Abstract][Full Text] [Related]
7. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder. Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322 [TBL] [Abstract][Full Text] [Related]
8. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663 [TBL] [Abstract][Full Text] [Related]
9. The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer. Bowyer L; Hall RR; Reading J; Marsh MM Br J Urol; 1995 Feb; 75(2):188-92. PubMed ID: 7850324 [TBL] [Abstract][Full Text] [Related]
10. Screening urine analysis before bacille Calmette-Guérin instillation does not reduce the rate of infectious complications. Zhao LC; Meeks JJ; Helfand BT; Ross FR; Herr HW; Kundu SD BJU Int; 2012 Jun; 109(12):1819-21. PubMed ID: 22077819 [TBL] [Abstract][Full Text] [Related]
11. Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures. Joudi FN; O'Donnell MA Curr Opin Urol; 2004 Sep; 14(5):271-5. PubMed ID: 15300147 [TBL] [Abstract][Full Text] [Related]
12. Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis. Huang D; Jin YH; Weng H; Huang Q; Zeng XT; Wang XH Front Oncol; 2019; 9():121. PubMed ID: 30881921 [No Abstract] [Full Text] [Related]
13. Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder. Elzein F; Albogami N; Saad M; El Tayeb N; Alghamdi A; Elyamany G Clin Med Insights Case Rep; 2016; 9():71-3. PubMed ID: 27559301 [TBL] [Abstract][Full Text] [Related]
14. Prevention of the Recurrence of Superficial Bladder Cancers: Intravesical Instillation of Bacillus Calmette-guerin Versus Bacillus Calmette-guerin Plus Epirubicin. Tozawa K; Okamura T; Yamada Y; Hayashi Y; Sasaki S; Kohri K Asian Pac J Cancer Prev; 2000; 1(3):217-220. PubMed ID: 12718668 [TBL] [Abstract][Full Text] [Related]
15. Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies. Kamat AM; Willis DL; Dickstein RJ; Anderson R; Nogueras-González G; Katz RL; Wu X; Barton Grossman H; Dinney CP BJU Int; 2016 May; 117(5):754-60. PubMed ID: 26032953 [TBL] [Abstract][Full Text] [Related]
18. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group. Witjes JA; v d Meijden AP; Collette L; Sylvester R; Debruyne FM; van Aubel A; Witjes WP Urology; 1998 Sep; 52(3):403-10. PubMed ID: 9730451 [TBL] [Abstract][Full Text] [Related]
20. Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy. Gallagher BL; Joudi FN; Maymí JL; O'Donnell MA Urology; 2008 Feb; 71(2):297-301. PubMed ID: 18308107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]